Gender-based comparative toxicity of di-ethyl phthalate in Wistar rats

In recent years, the exposure of humans to phthalate esters through environmental contamination has increased. One among them is di-ethyl phthalate (DEP), which is used as a plastisizer for cellulose ester plastic films and sheets, solid rocket propellants, molded and extruded articles, as a component in insecticide sprays and various other substances, as well as in industrial applications. Release into the environment occurs primarily as a result of production and manufacturing of DEP and during the use and disposal of products containing DEP. Therefore, a study was undertaken to evaluate gender-specific toxicity of DEP in Wistar rats. Rats of both sexes, weighing 125–130?g, were administered 50?ppm (w/v) DEP in water ad libitum for a period of 180 days and were given normal diet. Control animals received normal diet and water ad libitum. During the treatment, rats were weighed every week and water consumption per day was measured. After the completion of treatment, liver weight?:?body weight^?1 ratio, liver weight, body weight^?1, liver and serum enzymes, and other biochemical parameters of liver and serum were assessed. It was observed that there was no significant change in body weight^?1, liver weight, liver weight?: body weight^?1 ratio, and water consumption in both sexes. There were significant increases in liver acid phosphatase (ACP) activity and kidney glutathione levels, and nonsignificant changes in liver alkaline phosphatase (ALP), aspartate aminotransferase (AST), alanine aminotransferase (ALT), succinate dehydrogenase (SDH), and lactate dehydrogenase (LDH) activities in DEP-treated male rats, whereas in DEP-treated female rats the liver showed significant decrease in ALP and SDH and nonsignificant changes in AST, ALT, and LDH activities. Serum ACP and LDH levels in DEP-treated male rats were significantly decreased, and in the case of DEP-treated female rats, only serum LDH levels were significantly decreased. There was no significant change in serum ALP, AST, and SDH levels in DEP-treated male and female rats as compared to control rats. Histology of the livers of both male and female rats showed loss of hepatic architecture, degenerative changes in hepatocytes, and vacuolation in hepatocytes in both the centrilobular and periportal areas. It can be concluded from this study that prolonged exposure to DEP at 50?ppm levels can be harmful to animals and humans. This is evident from the present study as certain significant changes in enzyme activities in the liver, serum, and histological alterations in liver were observed.     

Lead-induced alterations in protein-deficient rat liver–role of zinc

This study was designed to determine the protective effects of zinc (Zn) using liver marker enzymes in the serum and liver along with hepatic elemental profile in lead (Pb)-treated protein-deficient (PD) Sprague–Dawley male rats. Zn in the form of zinc sulfate at a dose of 227?mg?L^?1 in drinking water was administrated to control, PD as well as Pb-treated PD rats for 8 weeks. Pb treatment was given orally as lead acetate at a dose level of 100?mg?kg^?1 body weight to control and PD rats. The effects of different treatments were studied on the activities of enzymes that included alkaline phosphatase (ALP), aspartate aminotransferase (AST) and alanine aminotransferase (ALT) in serum. The status of different elements (Cl, K, Mn, Fe, Cu, Zn, Se, Rb, Pb) in liver was also studied. Rats given PD diet and Pb showed significant inhibition in serum ALP activity associated with significant elevation in both AST and ALT activities. Serum ALP activity showed a significant inhibition week 1 until week 8 in Pb-treated PD rats. In contrast, serum AST activity was elevated both at 3 and 8 weeks while serum ALT activity was elevated at 8 weeks in Pb-treated PD rats. Pb treatment to PD rats elevated hepatic ALP, AST and ALT activities but depressed hepatic AST. Zn supplementation to Pb-treated PD rats restored the altered enzyme activities. The levels of K, Fe, Cu, Zn, Se and Rb were altered in protein deficiency. Furthermore, treatment with Pb to these animals depressed the Cu levels. Zn treatment to Pb-treated PD animals tended to restore the levels of altered elements. Hence, the present study clearly suggests that Zn plays an important role in regulating the liver marker enzymes and essential elements under conditions of Pb toxicity and protein deficiency.     

Protective effects of Peganum harmala extracts on thiourea-induced diseases in adult male rat

Cancers and hepatoprotective prevention using traditional medicines have attracted increasing interest. The aim of our study was to characterize the putative protective effects of ethanol and chloroform extracts of Peganum harmala on thiourea-induced diseases in adult male rat. We seek to determine the effects of these plant extracts on body weight, thyroid and endocrine cancer parameters. In addition the putative hepatoprotective effect was checked by the determination of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activities and the bilirubin level in the blood. Our data show that ethanol and chloroform extracts of Peganum harmala protected the animal against the carcinogenic effects induced by thiourea since neuron-specific enolase (NSE) and thyroglobulin (TG) levels were back to the normal range. In addition, the observed-hepatocytotoxicity after thiourea treatment was greatly reduced (AST and ALT activities were respectively 270 IU/l and 60 IU/l and in the same order of magnitude as in the untreated rats) as well as the bilirubin levels (6 micromol/l) especially for animals receiving the choroform preparation. Therefore we may suggest that extracts of Peganum harmala are efficient to reduce the toxicity induced by thiourea in male rat as far as the above parameters are concerned.     

Potential hepatoprotective effects of vitamin E and Nigella sativa oil on hepatotoxicity induced by chronic exposure to malathion in human and male albino rats

Malathion is an organophosphorus (OP) insecticide and has a wide range of use in agriculture, veterinary medicine, and public health. Malathion and other OP insecticides produce hepatotoxic effects. The objective of the present study was to investigate the protective effects of Nigella sativa oil and α-tocopherol (vitamin E) on the hepatotoxicity induced by malathion on workers involved in the formulation of pesticides, chronically exposed to malathion, and in male albino rats orally administrated malathion. This study was conducted on both human and experimental animals, the human study was conducted on 30 control subjects working as administrators and 45 subjects working in formulation of pesticides and exposed to malathion (≥3 years), all were males with age ranges from 30 to 60 years. The 45 males working in pesticides formulation were classified into three groups; (1) 15 workers exposed to pesticides (2) 15 workers exposed to pesticides and received vitamin (E), in a dose of 10 mg kg?1 day^?1 orally for 60 days, and (3) 15 workers exposed to pesticides and received 100 mg kg^?1 day^?1 of N. sativa oil for 60 days. The animal experiment was conducted on 40 adult male albino rats weighing 150–200 g. They were divided into four groups (10 rats in each group). First group served as the control group, the second group received malathion in a dose of 50 mg kg^?1 orally per day for 60 days, the third group received malathion (in the same dose and route of administration) and vitamin E in a dose of 10 mg kg^?1 day^?1 orally for 60 days, and the fourth group received malathion (in the same dose and route of administration) and N. sativa oil in a dose of 100 mg kg^?1 day^?1 orally for 60 days. Liver function tests (alanine aminotransferase [ALT], aspartate aminotransferase [AST], serum alkaline phosphatase [ALP], albumin, globulin, albumin/globulin ratio, and total proteins), antioxidant enzymes (catalase (CAT), superoxide dismutase (SOD), and total glutathione peroxidase (GPx)), and lipid peroxidation [MDA] were analyzed in both human and animal experiments. The results of both human and animal study revealed that, exposure to malathion produced significant increases in AST, ALT, and lipid peroxidation. There were significant decrease in albumin, albumin/globulin ratio, total protein, and antioxidant enzymes. There was no significant change in ALP. In addition exposed workers showed significant decreases in serum globulin. Nigella sativa oil or vitamin E administration showed significant improvement of liver function tests, lipid peroxidation, and antioxidant enzymes impairment induced by malathion. Thus, dietary supplement, N. sativa oil, or vitamin E may represent a potential therapeutic agent in reducing malathion-induced hepatotoxicity.     

火箭推进剂单推-Ⅲ对大鼠肝、肾的毒性效应

为探讨新型火箭推进剂单推-Ⅲ(主成分为肼)对大鼠肝、肾的毒性效应及其作用机制,将24只雄性Wistar大鼠随机分为4组:生理盐水对照组,低剂量组、中剂量组和高剂量组,采用灌胃方式染毒,单次染毒剂量分别为0、0.70、2.35、7.05mg·kg-1(以单推-Ⅲ中的肼计算),每天1次,连续染毒7d,眼眶静脉丛取血后腹主动脉放血处死大鼠,称肝、肾重量计算肝、肾的脏器系数,测定大鼠血清中反映肝、肾功能的生化指标,并对肝、肾进行病理学观察.结果表明,1)单推-Ⅲ染毒可导致大鼠出现后肢运动障碍,并显著提高大鼠肝、肾脏器系数及血糖水平;2)病理学观察发现,单推-Ⅲ染毒可导致大鼠肝脏灶性及汇管区少量炎症细胞浸润,肝细胞脂肪变性,肾脏则无明显改变;3)单推-Ⅲ染毒可导致大鼠肝功能异常,部分肝功能指标如谷丙转氨酶(ALT)、谷草转氨酶(AST)、碱性磷酸酶(ALP)、直接胆红素(D-BIL)等出现显著升高或降低;4)单推-Ⅲ染毒可导致大鼠肾功能异常,部分肾功能指标如尿素氮(BUN)、尿酸(UA)、肌酐(CREA)等出现显著升高或降低.综合以上实验结果可以看出火箭推进剂单推-Ⅲ对大鼠肝、肾组织可产生一定的毒性效应,并可造成一定程度的中枢神经损伤。     

Hepatoprotective activity of 1-(4-(Dimethylamino)Benzylidene)-5-(2-Oxoindolin-3-ylidene) Thiocarbohydrazone in rats

The aim of the present study was to evaluate the hepatoprotective activity of 1-(4-(dimethylamino)benzylidene)-5-(2-oxoindolin-3-ylidene) thiocarbohydrazone, a novel isatin derivative against carbon tetrachloride (CCl₄)-induced hepatotoxicity in rats. Hepatic damage was induced by administration of CCl₄ (1 ml/kg, b.w., p.o.) in combination with liquid paraffin (1:1) as a single dose. The hepatotoxic rats were treated with test compound at doses of 50 or 100 mg/kg for three days and liver damage biomarkers, including activities of serum glutamate pyruvate transaminase (SGPT), serum glutamate oxaloacetate transaminase (SGOT), serum alkaline phosphatase (ALP), and levels of total serum bilirubin (TB) measured in blood samples. Results demonstrated that treatment with test compound at doses of 50 or 100 mg/kg to hepatotoxic rats produced a significant dose-dependent reduction of elevated SGOT, SGPT, ALP activities and TB levels indicating a hepatoprotective effect that was confirmed by histopathological examination of liver tissues. The study results confirmed the hepatoprotective activity of 1-(4-(dimethylamino)benzylidene)-5-(2-oxoindolin-3-ylidene) thiocarbohydrazone in rats.     

Protective effects of honey against cadmium-induced alteration of some biochemical parameters in rats

The objective of this study is to elucidate on the effect of honey on plasma and organ biochemical parameters of albino rats exposed to acute and sub-chronic dose of cadmium chloride. Uric acid levels, activities of plasma lactate dehydrogenase (LDH), aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activities, organ (liver, lungs, and kidney) AST, ALT, superoxide dismutase (SOD), and catalase (CAT) were determined. Plasma uric acid and glucose levels, plasma LDH, AST, and ALT activities were significantly decreased; activities of organ SOD, CAT, AST, and ALT activities were increased in rats administered sub-chronically and acutely with cadmium (Cd). Treatment with honey restored their levels to normal.     

Biochemical evaluation of multiple herbal treatments in alloxan-induced diabetes in Wistar rats

Alloxan-induced diabetic rats were treated with multiple herbal preparation besides a control group receiving distilled water. The levels of glucose and alkaline phosphatase (ALP) increased abnormally in the alloxan treated group and the same were normalized upon treatment with the herbal preparation. The levels of blood urea nitrogen (BUN), alanine aminotransferase (ALT), protein and albumin in all groups remained unaltered. However, weekly body weight gain which got significantly altered in the alloxan-treated group was normalized by treatment with the herbal preparation. On the whole, a profound hypoglycemic effect was observed by the multiple herbal treatment in the diabetic rats.     

Effect of alloxan induced diabetes on liver and kidney function in arsenic treated rats

Experiments were performed to study the effects of inorganic arsenic (iAs) on liver and kidney functions of diabetic rats. Data showed that arsenic concentration decreases in the liver and kidneys of rats in hyperglycemic conditions. Alanine aminotransferase (ALT) activity was markedly less in arsenic-diabetic rats compared to arsenic alone; however, hyperbilirubinemia was observed in arsenic-diabetic animals. Creatinine values showed improved kidney function in arsenic-diabetic rats compared to arsenic alone. Histopathological observations were less severe in inorganic arsenic liver and kidneys of alloxan-diabetic rats. These observations were considered to be important since they partially argue against earlier reports that demonstrated a diabetogenic effect attributed to arsenic.     

Chronic mixture toxicity study of Clophen A60 and diethyl phthalate in male rats

Chemical mixtures are an important area of research as individuals are exposed to low doses of persistent chemical agents known as environmental pollutants throughout their life time. Polychlorinated biphenyls (PCBs) and diethyl phthalate (DEP) are ubiquitous environmental pollutants that could be present in the same environmental compartment; hence organisms may get simultaneously exposed to both. Therefore, a study was undertaken to see whether PCB and DEP together show interactive chronic mixture toxicity in male Wistar rats. Healthy male Wistar rats weighing 70–100?g were randomly assigned to four groups of six each. Control rats were fed on normal diet and water ad libitum. Oil control rats were maintained on a normal diet mixed with corn oil. Rats were given Clophen A60 (PCB) and DEP dissolved individually in corn oil mixed with the diet at 50?mg?kg^?1 of the diet/day, as well as a mixture in corn oil mixed with the diet both at 50?mg?kg^?1 of the diet/day. After 150 days of treatment animals were sacrificed and enzymes and other biochemical parameters in the serum and liver were assessed. Liver weight to body weight ratio showed a significant increase in Clophen A60 and in Clophen A60?+?DEP treated rats. In the DEP, Clophen A60 and Clophen A60?+?DEP treated groups there was significant increase in liver and serum alanine aminotransferase (ALT) and acid phosphatase (ACP) activity. Aspartate aminotransferase (AST) was significantly increased in the liver and serum of DEP treated rats only. Cholesterol levels were significantly increased only in the serum and the liver of DEP treated rats. Triglyceride levels were significantly increased in the serum of treated rats and only in the liver of Clophen A60 and Clophen A60?+?DEP treated rats. Liver glycogen levels were significantly increased in DEP and Clophen A60?+?DEP treated rats. In all treated animals, there was a significant decrease in liver glutathione reductase (GR). Histology of liver showed severe vacuolations, fatty degeneration and loss of hepatic architecture in Clophen A60 and Clophen A60?+?DEP treated rats, whereas in DEP treated rats only loss of hepatic architecture and granular deposits in the hepatocytes was predominant with mild vacuolations of centrilobular and periportal area. It is evident from this study of mixture toxicity of Clophen A60 and DEP that there is no significantly enhanced toxicity due to the interaction of these two compounds. On the other hand, to some extent there is alleviation in toxicity as evidenced by enzyme ACP and AST levels in the liver. The hepatocellular damage and biliary congestion caused by these two compounds, which can be confirmed by significantly increased liver weights and elevated serum and liver enzyme levels as well as histology, was almost the same between individual and mixture treated group.     

14C-Ethion residues in soybean seeds: metabolic pathway,effect of processing,bioavailability, toxicity and protective action of artichoke leaf powder towards rats

The metabolic fate of ethion labeled with ¹⁴C-at the ethyl ester groups in soybean seeds following topical application to leaves was studied. Chromatographic analysis of soybean oil revealed the presence of the parent compound together with four metabolites which were identified as ethion monooxon, ethion dioxon, O-ethyl phosphorothioate and O,O-diethyl phosphorothioate. The effect of processing on ethion residues in soybean oil was investigated. The refined oil contained small amounts of the ¹⁴C-residues originally present (37.5%). Upon feeding rats with the cake containing ethion bound residues, a substantial amount of ¹⁴C-residues was eliminated in the urine (73%), and about 6% excreted with the feces. About 5% of the radioactive residues were distributed among various organs. Mature male Wistar rats were fed on soybean seeds containing ethion residues (1.93 ppm), and on artichoke leaves powder (1% W/W) for four weeks. At the end of the experimental period, the ethion-treated group had a significantly higher alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP) activity, urea, creatinine, total cholesterol (TC), triglycerides (TG), and very low density lipoprotein (VLDL) levels. The ethion-treated rats also had a lower total serum protein and albumin levels, as well as acetyl cholinesterase (AChE), catalase (CAT), and glutathione-S-transferase (GST) activity as compared with controls. Moreover, concomitant treatment with artichoke leaf powder improved, at least partially, all the biochemical parameters that were altered by ethion.     

运动对2,3,7,8-四氯二苯并二噁英持续暴露大鼠肝脏氧化应激的影响

为探索运动对2,3,7,8-四氯二苯并二噁英(2,3,7,8-TCDD)持续暴露大鼠肝脏氧化应激的影响,本研究将7周龄雄性SD大鼠适应性喂养1周后,随机分为对照(NC)、运动对照(EC)、染毒1(NT1)、运动染毒1(ET1)、染毒2(NT2)、运动染毒2(ET2)、染毒3(NT3)、运动染毒3(ET3)、染毒4(NT4)及运动染毒4(ET4)共10组。染毒组(NTs、ETs)腹腔注射TCDD(溶于玉米油),对照组及各染毒组首次剂量依次为0、0.4、1.6、6.4、25.6μg·kg~(-1)(以单位体重计),之后每周给予上述剂量的21%作为维持剂量,持续染毒8周;运动组尾部负重5%游泳,每周5 d,每次30 min。实验结束取材,测定血清丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)、肝组织超氧化物歧化酶(SOD)、过氧化氢酶(CAT)、谷胱甘肽过氧化物酶(GSH-Px)活性及丙二醛(MDA)、活性氧(ROS)含量。结果显示:1)染毒可升高各染毒组大鼠血清AST活性及NT4组大鼠血清ALT活性,增加NT2、NT3组肝脏MDA含量,而降低NT1、NT2组大鼠血清ALT活性;2)运动可升高大鼠血清AST及ALT活性,增加大鼠肝组织GSH-Px活性;3)运动可升高染毒大鼠血清AST活性(T1剂量),降低染毒大鼠血清ALT活性(T1剂量),降低染毒大鼠血清AST活性(T3剂量),升高染毒大鼠血清ALT活性(T3、T4剂量),增加染毒大鼠肝组织SOD活性(T2、T3剂量)、CAT活性(T1、T2、T3剂量)及GSH-Px活性(T2、T3、T4剂量),降低染毒大鼠肝组织MDA含量(T2、T3、T4剂量)及ROS含量(T1、T3剂量)。结果表明,2,3,7,8-TCDD持续暴露8周可引起大鼠肝细胞氧化应激损伤,并产生剂量依赖效应;而有氧运动可增加2,3,7,8-TCDD持续暴露(T2、T3剂量)大鼠肝组织抗氧化酶活性,有效降低氧化应激损伤而减轻肝毒性。     

非暴露式气管滴注3种典型纳米材料对大鼠肝、肾的毒性效应

为探讨纳米二氧化硅(Nano-SiO2)、纳米四氧化三铁(Nano-Fe3O4)和单壁碳纳米管(SWCNTs)对大鼠肝、肾的毒性效应,将49只雄性Wistar大鼠随机分为7组,包括生理盐水对照组,以及3种纳米材料的低剂量组(2mg·mL-1)和高剂量组(10mg·mL-1),采用非暴露式气管滴注法染毒,每2d染毒1次,每次每只0.2mL,共染毒5周,眼眶取血后处死大鼠,称肝、肾重量计算脏器系数,测定大鼠血清中反映肝、肾功能的生化指标,并对肝、肾进行病理学观察.结果表明,1)3种纳米材料均可导致大鼠体重明显降低,但对肝、肾脏器系数无明显影响;2)病理学观察发现,3种纳米材料均可导致大鼠肝细胞轻度脂肪变性,肾脏则无明显改变;3)3种纳米材料均可导致大鼠肝功能异常,部分肝功能指标如谷草转氨酶(AST)、碱性磷酸酶(ALP)、谷丙转氨酶(ALT)等出现显著降低;4)3种纳米材料均可导致大鼠肾功能异常,部分肾功能指标如尿酸(UA)、肌酐(CREA)、尿素氮(BUN)等出现显著升高或降低.以上结果提示,经呼吸道染毒的Nano-SiO2、Nano-Fe3O4和SWCNTs均可对大鼠肝、肾产生一定的毒性效应.     

内质网应激在PFOS致大鼠肝损伤中的作用

通过全氟辛烷磺酸(PFOS)28 d大鼠经口染毒评价PFOS肝损伤效应,探讨内质网应激在PFOS毒效应中的作用。Wistar大鼠随机分组,分别以0 mg·kg~(-1)、5 mg·kg~(-1)和10 mg·kg~(-1)PFOS灌胃染毒28 d。HE染色观察大鼠肝脏形态改变。ELISA法测定各组丙氨酸转氨酶(ALT)、天门冬氨酸转氨酶(AST)、碱性磷酸酶(ALP)和淀粉酶(AMY)含量变化。紫外分光光度法测定肝组织匀浆中丙二醛(MDA)、超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-Px)活性变化。RT-PCR检测肝脏内质网应激标志蛋白表达水平。结果表明,PFOS造成大鼠体重降低、肝重增高(P0.05),组织切片显示肝细胞出现脂质沉积。PFOS不同剂量组大鼠ALT随暴露浓度增加,分别为(50.96±10.02)U·L~(-1)、(71.73±11.55)U·L~(-1),显著高于对照组(P0.05),AST、ALP含量与对照组相比显著上升(P0.05),高剂量组AMY水平为(833.46±63.05)U·L~(-1),与对照组相比显著降低(P0.05)。GSH-Px和SOD水平随PFOS浓度增加出现了显著降低(P0.05),而MDA水平显著升高(P0.05)。内质网应激标志蛋白表达均较对照组显著上升(P0.05)。以上结果说明PFOS可导致大鼠肝细胞损伤,其机制可能与内质网应激调控有关。     

Antioxidant effect of L-cysteine on sodium-valproate-induced oxidative stress in rat liver: biochemical and ultrastructural approaches

L-Cysteine has protective efficacy in cases of oxidative tissue injury. Sodium valproate is widely used as an anticonvulsant and an antidepressant in spite of hepatotoxicity as side effect. The aim of this study was to evaluate the protective role of L-cysteine in liver toxicity induced by sodium valproate overdose. Release of the hepatic enzymes, aspartate aminotransferase and alanine aminotransferase, and levels of lipid profiles, as well as the oxidative, enzymatic, and non-enzymatic antioxidant were assessed. Liver damage was judged histologically. L-Cysteine decreased the activity of alanine aminotransferase and aspartate aminotransferase, as well as improved the level of lipid profile, increased the enzymatic antioxidant (catalase, superoxide dismutase, glutathione peroxidase and glutathione reductase), and decreased the lipid peroxidation. L-Cysteine administration inhibited liver injury of sodium valproate.     

Hepatoprotective effects of taurine against mercury induced toxicity in rats

An attempt has been made to study the influence of taurine on mercury intoxicated rats. The animals were treated with sublethal dose of mercuric chloride (2 mg/kg body wt.) for 30 days. During the mercury treatment, the level ofAspartate transaminase(AST), Alanine transaminase (ALT) and Alkaline phosphatase(ALP) in serum and lipid peroxidation (LPO) in liver tissue significantly increased whereas Glutathione (GSH), Glutathione peroxidase(GPx), Catalase (CAT) and Superoxide dismutase (SOD) were simultaneously decreased in the liver tissue. Present results indicate that the liver tissue was completely damaged, after mercury treatment. In another group of animals, taurine (5 mg/kg body wt.) was administrated for another 15 days. Taurine administration was observed to improve the liver function in mercury intoxicated animal as indicated by the decline in increased levels of AST, ALT and ALP in serum and LPO content in liver tissue. The decreased level of antioxidant system (GSH, GPx, CATand SOD) has been promoted Results suggested that taurine played a vital role in reducing the mercury toxicity in intoxicated animals.     

伊维菌素对雄性吉富罗非鱼生理生化指标的影响

为探讨抗寄生虫药物伊维菌素(IVM)对鱼类的毒性效应,以雄性吉富罗非鱼(Oreochromis niloticus)为实验对象,设定了A(空白对照)、B(乙醇对照)、C(0.1 mg·kg~(-1))、D(0.5 mg·kg~(-1))、E(1 mg·kg~(-1))5个实验组,研究IVM对吉富罗非鱼肝脏和血液生理生化的影响。研究发现:正常生理状态下吉富罗非鱼肝脏中的丙二醛(MDA)含量较低,IVM作用后除最高剂量E组中MDA含量在4 h、16 h和24 h时极显著高于对照组外,其余各组均未受到显著影响。较低注射剂量C组中超氧化物歧化酶(SOD)活性均得到了诱导,且均显著高于对照组,较高注射剂量组中除E组在第4 h、16 h和24 h SOD活性显著高于对照组外,其余均未发现有显著变化。肝脏中谷草转氨酶(AST)和谷丙转氨酶(ALT)在IVM作用下均发生了一定的变化,尤其是E组均显著低于对照组。与肝脏中的相反,血液中的AST则随剂量的升高而呈现增加的趋势,在某些时间点与对照组相比显著升高,而血液中ALT除C、D组个别时间点外其余的均未有显著变化。B、C、D、E 4组肝脏中的碱性磷酸酶(ALP)相对A组均发生了显著下降,但C、D、E组与B组除个别时间点外均未有显著差异,因此肝脏中的ALP变化可能是无水乙醇作用的结果,而非IVM。血液中ALP则均未有显著变化。研究表明高剂量的IVM对吉富罗非鱼的肝脏造成了一定影响,因此在实际使用过程中应选择合适的给药方式以及合理的给药剂量。     

Sub-chronic exposure to carbendazim induces biochemical and hematological alterations in male goats

The present investigation reports the effect of repeated (90 days) administration of carbendazim on the biochemical and hematological parameters in male goats. Carbendazim administered orally at a daily dose of 50 mg kg^?1 body weight for 90 consecutive days resulted in increased plasma concentration of aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LDH), gamma-glutamyl transferase (GGT), creatinine and albumin, while alkaline phosphatase (ALP) and glucose levels were decreased. Decrease in total leukocyte (TLC) and neutrophil count and increase in lymphocyte count was observed in the treatment group. The findings of the present investigation indicate that sub-chronic exposure to carbendazim in male goats causes hepatic and slight kidney dysfunctions.     

Toxicological studies of zinc oxide nanomaterials in rats

In this study, we have evaluated the ability of zinc oxide (ZnO) nanoparticles to induce pulmonary and extrapulmonary toxicities was examined in rats following intratracheal (IT) instillation. Lungs of rats were instilled IT with either phosphate-buffered saline (PBS)?+?1% Tween 80, ZnO nanoparticles, carbonyl iron or quartz particles at a dose of 1 or 5?mg?kg^?1 body weight. Following exposure, bronchoalveolar lavage (BAL) fluid, blood samples and organs including lung, liver, kidneys, heart, pancreas, and brain were collected at 24?h, 1 week, or 1 month of post instillation of nanoparticles and different parameters estimated to assess toxicity. BAL fluid was analyzed for lactate dehydrogenase (LDH) and alkaline phosphatase (ALP) to assess pulmonary toxicity. Exposures to ZnO or quartz particles produced transient dose-dependant increase in BAL fluid LDH and ALP activities at all post exposure periods. Blood samples were analyzed for the tissue damage biomarkers to assess extrapulmonary toxicity. Histopathological examination of lung, liver and kidneys revealed dose-dependent degeneration and necrosis which worsened at 1 week post-instillation periods but recovered at 1 month post instillation. Histopathological examination of rat pancreas, heart, and brain exposed to quartz or ZnO particles showed no marked changes. Data suggest the instillation of ZnO nanoparticles produced a greater pulmonary toxicity in rats comparable with quartz; and extrapulmonary toxicities of these ZnO nanoparticles might be due to translocation into liver and kidney.     

Sub-chronic oral toxicity of acetamiprid in Wistar rats

Acetamiprid is a neoncotinoid insecticide that acts as an agonist to the nicotinic acetylcholine receptor used as insecticide in crops and to control fleas on dogs and cats. The objectives of this study are (1) to evaluate the sub-chronic toxicity of orally administered acetamiprid, (2) to estimate the tissue residue levels and (3) to assess the reactive oxygen species induction in Wistar rats. Clinical signs of toxicity and changes in the haematological parameters were not observed in the acetamiprid-treated groups. Biochemically, increases in the levels of alanine aminotransferase, aspartate aminotransferase, cholesterol and decreases in body weight, feed consumption, reduced glutathione, catalase, superoxide dismutase, glutathione peroxidase, and AchE were observed. Lipid peroxidation was increased in liver and kidney. Acetamiprid residues persisted in liver, kidney, spleen, muscles, brain, fat and histopathology revealed lesions in the liver. The no observable adverse effect level of acetamiprid was found to be ≤55 mg/kg body weight.